InvestorsHub Logo
Followers 17
Posts 1681
Boards Moderated 0
Alias Born 03/14/2004

Re: slops post# 62927

Wednesday, 12/14/2022 3:31:04 PM

Wednesday, December 14, 2022 3:31:04 PM

Post# of 73559
The point in my view is that our Nigerian counterpart is completely unreliable and has no credibility. He has a long history of issuing PRs with lots of neat little buzz words/phrases like "FDA-registered", "distribution networks", "sales and distribution", "hospital chains", "ramp up production", "cannabis", etc., etc. that garner trading interest but never come to fruition. People on this thread could list them all out much quicker than I. The Company has accounts receivables that they never collect. They have no real sales of product and no inventory. Our leader is now in the negligent habit of ignoring SEC financial reporting deadlines. So...when we hear that more shares have been authorized without any notation of any restrictions, (despite the company conveying to you that the shares can't be sold for 2 years), no one really believes that the shares will be used for anything other than the Doc lining his own pockets or funding Wound Pros (which competes directly against ViaDerma by selling Tetracyte), or ViaDerma Distribution, Inc. (which is privately owned yet trading off of the public company name). This company, complete with its yield sign and illusory promises, exhibits all of the flashing warning lights of a company to avoid. ALL OF THIS IS IN MY HUMBLE OPINION.